S&P 500 7,637.76 +1.14%
Nasdaq 26,418.30 +1.69%
S&P/TSX 35,874.26 +1.08%
Apple 337.00 +1.38%
Nvidia 219.34 +2.54%
Microsoft 497.75 +1.52%
Shopify 180.01 −0.97%
Royal Bank 284.93 +0.66%
CAD/USD 0.7155 +0.09%
CLOSED · 00:05 ET
Market ClerkRecap
Fri Sep 18 · markets closed3 signals on Sep 17300 insider buys this week · $205.1MCIRO short report next: Sep 29The week ahead

TRVI

Trevi Therapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
15.21
+0.20 +1.33%
USD · close Sep 17

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

One year, everything drawn on

251 SESSIONS · DAILY CLOSES
2016127.24Sep 15 · Director sell $2KSep 15 · Director sell $316KSep 15 · Director sell $2KSep 15 · Director sell $276KSEP 2025OCTJAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-17
Shorts (latest report): 12M short · −645K last period
Every line of the math
63WATCH

Congress is trading it

No STOCK Act disclosure names TRVI.

Insider activity

ALL 4
DateInsiderTypeValue
Sep 15DirectorSell$2K
Sep 15DirectorSell$316K
Sep 15DirectorSell$2K
Sep 15DirectorSell$276K
Watch TRVI. Know when insiders buy.
One email the day a filing lands. Free.